Free Trial
→ Watch This Robotics Demo Before July 23rd (From Brownstone Research) (Ad) Buy ACXM Stock  Free ACXM Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Acxiom (ACXM) Financials

Acxiom logo
Compare
Annual Income Statements for Acxiom

Annual Income Statements for Acxiom

This table shows Acxiom's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 3/31/2014 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 8.86 -11 6.70 4.11 23 1,029 -125 -90 -34 -119 12
Consolidated Net Income / (Loss)		 8.80 -11 6.70 4.11 23 1,029 -125 -90 -34 -119 12
Net Income / (Loss) Continuing Operations		 -17 -27 -8.65 -86 -67 -134 -125 -90 -34 -124 10
Total Pre-Tax Income 		-5.30 -41 -20 -131 -133 -179 -166 -121 -35 -119 34
Total Operating Income		 1.56 -33 -13 -131 -134 -198 -181 -121 -66 -126 11
Total Gross Profit		 300 311 362 75 124 165 228 299 381 426 480
Total Revenue		 805 805 850 175 220 286 381 443 529 597 660
Operating Revenue		 805 805 850 175 220 286 381 443 529 597 660
Total Cost of Revenue		 506 494 488 100 96 121 153 144 147 170 179
Operating Cost of Revenue		 506 494 488 100 96 121 153 144 147 170 179
Total Operating Expenses		 298 344 375 206 257 363 409 420 447 552 469
Selling, General & Admin Expense		 117 153 148 98 88 99 109 104 105 125 110
Marketing Expense		 94 116 146 59 109 159 189 178 183 202 196
Research & Development Expense		 63 74 74 49 61 86 106 135 158 189 151
Other Operating Expenses / (Income)		 - - - - - 20 5.00 2.72 1.48 35 12
Total Other Income / (Expense), net		 -6.86 -8.66 -7.22 0.65 0.50 19 15 -0.25 30 6.95 23
Income Tax Expense		 12 -15 -12 -45 -66 -45 -40 -31 -1.24 5.25 24
Net Income / (Loss) Discontinued Operations		 26 16 15 90 91 1,162 0.75 0.00 0.00 5.40 1.79
Basic Earnings per Share		 $0.12 ($0.14) $0.09 $0.05 $0.30 $13.71 ($1.84) ($1.36) ($0.50) ($1.79) $0.18
Weighted Average Basic Shares Outstanding		 74.69M 77.11M 77.62M 82.20M 78.89M 75M 65.34M 68.41M 68.41M 66.40M 66.15M
Diluted Earnings per Share		 $0.12 ($0.14) $0.09 $0.05 $0.30 $13.71 ($1.84) ($1.36) ($0.50) ($1.79) $0.17
Weighted Average Diluted Shares Outstanding		 74.69M 77.11M 77.62M 82.20M 78.89M 75M 65.34M 68.41M 68.41M 66.40M 66.15M
Weighted Average Basic & Diluted Shares Outstanding		 74.69M 77.11M 77.62M 82.20M 78.89M 75M 65.34M 68.41M 68.41M 66.40M 66.15M

Quarterly Income Statements for Acxiom

This table shows Acxiom's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -27 -30 -30 -31 -1.59 4.86 14 -5.37 -7.49 1.73 11
Consolidated Net Income / (Loss)		 -27 -30 -30 -31 -1.59 4.86 14 -5.37 -7.49 1.73 11
Net Income / (Loss) Continuing Operations		 -27 -30 -31 -36 -1.59 4.48 13 -6.18 -7.49 1.73 9.52
Total Pre-Tax Income 		-25 -27 -25 -42 7.12 15 22 -9.21 -0.80 12 19
Total Operating Income		 -26 -29 -24 -47 2.27 8.21 15 -14 -5.25 7.49 15
Total Gross Profit		 101 105 115 105 108 119 129 124 124 134 140
Total Revenue		 142 147 159 149 154 160 174 172 176 185 195
Operating Revenue		 142 147 159 149 154 160 174 172 176 185 195
Total Cost of Revenue		 41 42 43 43 46 41 45 48 52 51 55
Operating Cost of Revenue		 41 42 43 43 46 41 45 48 52 51 55
Total Operating Expenses		 127 134 139 152 106 110 114 138 129 127 126
Selling, General & Admin Expense		 27 29 37 33 27 26 27 30 31 31 32
Marketing Expense		 51 46 48 58 45 44 46 60 54 51 51
Research & Development Expense		 48 46 43 52 35 34 38 45 44 44 43
Other Operating Expenses / (Income)		 0.74 13 12 9.72 0.12 6.57 2.50 2.52 0.21 0.40 0.15
Total Other Income / (Expense), net		 0.70 2.25 -0.74 4.74 4.85 6.43 6.61 5.07 4.44 4.20 4.03
Income Tax Expense		 2.32 3.56 5.84 -6.46 8.71 10 8.43 -3.03 6.69 9.95 9.18
Net Income / (Loss) Discontinued Operations		 - 0.00 0.84 - - 0.39 0.60 - - 0.00 1.69
Basic Earnings per Share		 ($0.40) ($0.45) ($0.46) ($0.48) ($0.02) $0.07 $0.21 ($0.08) ($0.11) $0.03 $0.17
Weighted Average Basic Shares Outstanding		 67.14M 66.48M 64.71M 66.40M 66.19M 65.51M 66.18M 66.15M 66.61M 65.26M 65.76M
Diluted Earnings per Share		 ($0.40) ($0.45) ($0.46) ($0.48) ($0.02) $0.07 $0.21 ($0.09) ($0.11) $0.03 $0.17
Weighted Average Diluted Shares Outstanding		 67.14M 66.48M 64.71M 66.40M 66.19M 65.51M 66.18M 66.15M 66.61M 65.26M 65.76M
Weighted Average Basic & Diluted Shares Outstanding		 67.14M 66.48M 64.71M 66.40M 66.19M 65.51M 66.18M 66.15M 66.61M 65.26M 65.76M

Annual Cash Flow Statements for Acxiom

This table details how cash moves in and out of Acxiom's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 3/31/2014 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Net Change in Cash & Equivalents		 196 -278 49 -20 -30 921 -329 -152 18 -136 -125
Net Cash From Operating Activities		 96 61 114 -26 -14 -1.98 -29 -21 78 34 106
Net Cash From Continuing Operating Activities		 96 61 114 -26 -14 -1.98 -29 -21 78 34 106
Net Income / (Loss) Continuing Operations		 -17 -27 -8.65 -86 -67 -134 -125 -90 -34 -124 10
Consolidated Net Income / (Loss)		 8.80 -11 6.70 4.11 23 1,029 -125 -90 -34 -119 12
Net Income / (Loss) Discontinued Operations		 26 16 15 90 91 1,162 0.75 0.00 0.00 5.40 1.79
Depreciation Expense		 57 80 85 32 38 34 36 28 24 21 12
Non-Cash Adjustments To Reconcile Net Income		 36 25 39 42 58 109 91 115 60 159 79
Changes in Operating Assets and Liabilities, net		 20 -18 -1.70 -15 -42 -11 -25 -73 36 -15 5.09
Net Cash From Investing Activities		 -55 -343 -69 -124 -14 -11 -116 -88 7.58 -29 -174
Net Cash From Continuing Investing Activities		 -55 -343 -69 -124 -14 -11 -116 -88 7.58 -29 -174
Purchase of Property, Plant & Equipment		 -58 -77 -64 -28 -13 -8.64 -12 -2.18 -4.50 -4.70 -4.26
Acquisitions		 -0.50 -266 -5.39 -138 -5.48 -2.50 -105 -78 -19 -0.50 -171
Purchase of Investments		 - - - - - 0.00 0.00 -7.50 0.00 -28 -49
Sale and/or Maturity of Investments		 3.82 - - - - - - 0.00 0.00 4.39 51
Other Investing Activities, net		 - - - - - - 0.00 0.00 31 0.00 0.00
Net Cash From Financing Activities		 103 -27 -126 26 -82 -842 -202 -43 -67 -146 -59
Net Cash From Continuing Financing Activities		 103 -27 -126 26 -82 -842 -202 -43 -67 -146 -59
Repurchase of Common Equity		 -53 -9.87 -53 -31 -89 -74 -182 -42 -59 -150 -61
Issuance of Common Equity		 80 5.04 10 21 20 20 4.74 8.74 6.27 6.26 7.22
Other Financing Activities, net		 11 4.65 3.55 -2.57 -11 -554 -25 -9.92 -15 -2.27 -5.84
Effect of Exchange Rate Changes		 0.62 -1.62 -0.38 -1.57 - -1.75 - - - - 0.37
Other Net Changes in Cash		 51 33 131 106 80 1,778 18 0.00 -0.20 4.85 1.79
Cash Income Taxes Paid		 22 -3.85 6.10 -6.87 -1.24 440 -7.34 -2.91 -33 5.80 2.47

Quarterly Cash Flow Statements for Acxiom

This table details how cash moves in and out of Acxiom's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -92 -23 -32 11 6.33 21 6.78 -159 -26 29 36
Net Cash From Operating Activities		 -33 21 16 31 26 36 17 28 -9.33 56 45
Net Cash From Continuing Operating Activities		 -33 21 16 31 26 36 17 28 -9.33 56 45
Net Income / (Loss) Continuing Operations		 -27 -30 -31 -36 -1.59 4.48 13 -6.18 -7.49 1.73 9.52
Consolidated Net Income / (Loss)		 -27 -30 -30 -31 -1.59 4.86 14 -5.37 -7.49 1.73 11
Net Income / (Loss) Discontinued Operations		 - - 0.84 4.57 - - 0.60 0.81 - - 1.69
Depreciation Expense		 5.74 5.69 5.13 4.23 4.04 1.86 1.78 3.82 4.55 4.45 4.40
Non-Cash Adjustments To Reconcile Net Income		 24 40 41 54 13 21 19 26 29 30 27
Changes in Operating Assets and Liabilities, net		 -36 6.67 -0.27 15 9.73 8.57 -10 4.31 -38 22 4.42
Net Cash From Investing Activities		 -1.74 -2.27 -0.68 -24 -0.55 0.67 -2.21 -172 -0.59 23 -1.24
Net Cash From Continuing Investing Activities		 -1.74 -2.27 -0.68 -24 -0.55 0.67 -2.21 -172 -0.59 23 -1.24
Purchase of Property, Plant & Equipment		 -1.74 -2.67 -0.18 -0.10 -0.05 -0.20 -2.21 -1.79 -0.23 -0.24 -0.28
Acquisitions		 0.00 - -0.50 - -0.50 -0.50 - -170 -0.40 - -2.95
Sale and/or Maturity of Investments		 - - 3.00 0.99 0.00 26 - 25 2.00 23 1.99
Net Cash From Financing Activities		 -56 -41 -49 -0.21 -19 -16 -8.90 -16 -16 -51 -9.36
Net Cash From Continuing Financing Activities		 -56 -41 -49 -0.21 -19 -16 -8.90 -16 -16 -51 -9.36
Repurchase of Common Equity		 -60 -40 -50 - -20 -15 -10 -15 -16 -50 -10
Issuance of Common Equity		 4.59 0.00 1.66 0.00 5.57 0.00 1.65 0.00 6.17 0.16 2.30
Other Financing Activities, net		 -0.58 -0.71 -0.76 -0.22 -3.89 -0.68 -0.55 -0.72 -6.85 -0.89 -1.57
Effect of Exchange Rate Changes		 -0.75 - - - - - - -0.45 - - -1.22
Other Net Changes in Cash		 - - 2.60 4.02 -0.29 0.68 1.42 0.81 -0.07 0.07 2.49
Cash Income Taxes Paid		 0.00 4.16 0.56 1.08 -29 3.51 23 4.91 -0.13 11 11

Annual Balance Sheets for Acxiom

This table presents Acxiom's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 3/31/2014 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Total Assets		 1,323 1,294 1,150 1,235 1,209 1,473 1,302 1,288 1,334 1,173 1,231
Total Current Assets		 666 511 376 369 361 1,192 896 826 816 715 602
Cash & Equivalents		 419 141 190 170 140 1,061 718 573 600 464 337
Restricted Cash		 0.00 31 - - - 0.00 15 8.90 - 0.00 2.60
Short-Term Investments		 - - - - - - - - 7.50 33 32
Accounts Receivable		 161 127 139 143 52 79 93 114 148 157 190
Current Deferred & Refundable Income Taxes		 24 5.24 9.83 7.10 9.98 7.89 38 66 30 29 8.52
Other Current Assets		 54 35 38 48 20 44 33 64 29 31 32
Plant, Property, & Equipment, net		 217 176 183 156 32 26 19 12 12 7.09 8.18
Total Noncurrent Assets		 441 606 591 710 817 255 386 451 506 451 621
Goodwill		 358 497 493 593 204 205 298 357 364 363 502
Intangible Assets		 19 9.55 10 56 14 29 45 40 27 9.87 35
Other Noncurrent Operating Assets		 64 99 81 51 38 22 43 53 116 78 85
Total Liabilities & Shareholders' Equity		 1,323 1,294 1,150 1,235 1,209 1,473 1,302 1,288 1,334 1,173 1,231
Total Liabilities		 640 591 451 496 460 142 214 208 271 247 282
Total Current Liabilities		 249 284 224 230 179 95 161 165 185 175 217
Accounts Payable		 36 30 38 40 19 31 57 49 83 87 81
Accrued Expenses		 70 63 48 60 40 41 69 58 46 36 43
Current Deferred Revenue		 48 34 44 37 4.51 4.28 6.58 12 16 19 31
Current Employee Benefit Liabilities		 62 37 61 53 14 19 29 46 39 33 62
Total Noncurrent Liabilities		 391 307 227 265 282 47 53 42 86 72 66
Other Noncurrent Operating Liabilities		 12 6.85 15 18 10 47 53 42 86 72 66
Commitments & Contingencies		 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 683 703 699 739 749 1,331 1,088 1,081 1,063 926 949
Total Preferred & Common Equity		 683 703 699 739 749 1,331 1,088 1,081 1,063 926 949
Preferred Stock		 - - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 683 703 699 739 749 1,331 1,088 1,081 1,063 926 949
Common Stock		 995 1,047 1,095 1,168 1,249 1,421 1,511 1,645 1,736 1,871 1,949
Retained Earnings		 603 592 599 603 628 1,670 1,545 1,455 1,421 1,302 1,314
Treasury Stock		 -928 -945 -1,003 -1,039 -1,139 -1,768 -1,974 -2,027 -2,100 -2,252 -2,318
Accumulated Other Comprehensive Income / (Loss)		 14 9.41 8.59 8.00 11 7.80 5.75 7.52 5.73 4.50 3.96

Quarterly Balance Sheets for Acxiom

This table presents Acxiom's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/31/2021 6/30/2022 9/30/2022 12/31/2022 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024
Total Assets		 1,343 1,234 1,188 1,166 1,164 1,181 1,225 1,206 1,195 1,253
Total Current Assets		 822 725 705 696 706 728 770 585 582 644
Cash & Equivalents		 553 508 486 454 471 492 499 310 339 377
Restricted Cash		 8.73 - - - - - - 2.62 2.63 0.59
Short-Term Investments		 - - - - 33 32 32 32 9.49 7.50
Accounts Receivable		 157 155 158 173 173 175 199 206 192 211
Current Deferred & Refundable Income Taxes		 63 29 30 27 0.00 0.00 1.14 1.93 4.20 6.63
Other Current Assets		 41 33 32 42 29 29 38 31 35 42
Plant, Property, & Equipment, net		 11 13 11 8.81 6.06 5.57 8.20 7.70 7.37 6.66
Total Noncurrent Assets		 510 496 473 461 452 447 447 614 605 603
Goodwill		 364 363 363 363 363 360 360 502 502 502
Intangible Assets		 32 22 17 13 6.58 5.36 4.18 31 27 23
Other Noncurrent Operating Assets		 115 111 93 85 82 82 82 81 76 78
Total Liabilities & Shareholders' Equity		 1,343 1,234 1,188 1,166 1,164 1,181 1,225 1,206 1,195 1,253
Total Liabilities		 272 229 228 255 245 259 278 254 263 296
Total Current Liabilities		 184 143 150 176 172 187 209 190 199 232
Accounts Payable		 80 67 70 84 74 79 89 85 91 105
Accrued Expenses		 56 42 41 42 39 37 43 43 45 46
Current Deferred Revenue		 15 15 16 16 27 21 30 38 36 45
Current Employee Benefit Liabilities		 32 20 23 33 24 35 47 23 27 36
Total Noncurrent Liabilities		 88 85 78 79 73 72 69 65 63 64
Other Noncurrent Operating Liabilities		 88 85 78 79 73 72 69 65 63 64
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,070 1,006 960 912 919 922 946 952 932 958
Total Preferred & Common Equity		 1,070 1,006 960 912 919 922 946 952 932 958
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,070 1,006 960 912 919 922 946 952 932 958
Common Stock		 1,704 1,769 1,796 1,826 1,889 1,905 1,925 1,982 2,010 2,038
Retained Earnings		 1,450 1,394 1,363 1,334 1,301 1,306 1,320 1,307 1,308 1,320
Treasury Stock		 -2,090 -2,160 -2,201 -2,252 -2,276 -2,292 -2,302 -2,341 -2,392 -2,403
Accumulated Other Comprehensive Income / (Loss)		 5.89 3.80 1.93 4.18 4.57 3.57 4.51 3.89 5.08 3.49

Annual Metrics and Ratios for Acxiom

This table displays calculated financial ratios and metrics derived from Acxiom's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 3/31/2014 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -24.62% -0.03% 5.61% -79.44% 25.94% 29.77% 33.24% 16.41% 19.33% 12.85% 10.57%
EBITDA Growth		 -72.20% -22.40% 55.76% -236.51% 3.59% -71.43% 8.56% 38.08% 47.06% -126.22% 120.56%
EBIT Growth		 -96.67% -1,098.96% 62.55% -942.04% -1.61% -48.40% 8.69% 33.23% 45.75% -91.95% 109.07%
NOPAT Growth		 -98.29% -2,199.17% 60.03% -905.99% -1.61% -48.40% 8.69% 33.37% 45.63% -91.95% 103.80%
Net Income Growth		 -84.59% -225.31% 160.77% -38.71% 471.57% 4,280.52% -112.11% 27.50% 62.52% -250.85% 110.01%
EPS Growth		 -84.00% -216.67% 164.29% -44.44% 500.00% 4,470.00% -113.42% 26.09% 63.24% -258.00% 109.50%
Operating Cash Flow Growth		 -35.01% -36.18% 85.90% -122.78% 45.57% 85.96% -1,344.64% 28.05% 479.75% -55.89% 206.77%
Free Cash Flow Firm Growth		 -2.80% -290.42% 88.91% -1,147.90% 336.82% -134.25% -37.52% -7.69% 99.00% -2,598.28% -136.57%
Invested Capital Growth		 -10.94% 19.80% 0.88% 14.04% -68.19% 6.14% 31.75% 40.61% -8.74% -5.84% 34.70%
Revenue Q/Q Growth		 -22.56% 31.82% 2.28% -80.14% 242.03% 180.69% 7.75% 3.14% 4.46% 1.17% 3.65%
EBITDA Q/Q Growth		 -67.18% 201.66% 0.17% -199.56% 57.99% -14.67% 19.11% -6.15% 24.17% -32.58% 340.24%
EBIT Q/Q Growth		 -95.88% 58.88% 22.42% -893.84% 41.27% -11.31% 18.60% -10.39% 26.75% -17.96% 153.17%
NOPAT Q/Q Growth		 -98.04% 60.26% 19.18% -596.36% 41.27% -11.31% 18.60% -10.16% 26.75% -17.96% -99.07%
Net Income Q/Q Growth		 -82.78% 67.76% 199.91% -61.31% 129.66% -4.69% 24.92% -46.66% 9.27% -1.69% 184.20%
EPS Q/Q Growth		 -82.09% 68.18% 0.00% 0.00% 0.00% -1.79% 4.66% -43.16% 10.71% -2.87% 177.27%
Operating Cash Flow Q/Q Growth		 -50.63% 1,124.82% 13.93% -120.16% 87.88% 95.98% -385.78% -610.68% 6,166.21% -45.09% -2.78%
Free Cash Flow Firm Q/Q Growth		 -36.29% 47.01% -116.00% -136.12% 376.16% -117.36% 69.83% -105.53% 98.71% -155.98% -136.18%
Invested Capital Q/Q Growth		 -7.80% -16.42% -3.26% -2.97% -69.28% 243.92% -1.56% 26.30% -10.48% -6.39% 39.09%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 37.21% 38.62% 42.55% 42.79% 56.20% 57.73% 59.88% 67.50% 72.11% 71.49% 72.79%
EBITDA Margin		 7.49% 5.81% 8.57% -56.91% -43.56% -57.55% -39.49% -21.01% -9.32% -18.68% 3.47%
Operating Margin		 0.19% -4.06% -1.54% -75.20% -60.66% -69.37% -47.54% -27.21% -12.40% -21.09% 1.73%
EBIT Margin		 0.42% -4.18% -1.48% -75.20% -60.66% -69.37% -47.54% -27.27% -12.40% -21.09% 1.73%
Profit (Net Income) Margin		 1.09% -1.37% 0.79% 2.35% 10.67% 360.11% -32.72% -20.38% -6.40% -19.90% 1.80%
Tax Burden Percent		 -166.09% 26.68% -33.05% -3.14% -17.65% -573.47% 75.22% 74.73% 96.46% 99.87% 34.58%
Interest Burden Percent		 -157.22% 122.78% 160.81% 99.50% 99.62% 90.52% 91.50% 100.00% 53.52% 94.48% 301.31%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.63%
Return on Invested Capital (ROIC)		 0.18% -3.60% -1.31% -12.29% -17.78% -53.03% -40.58% -19.76% -9.61% -19.92% 0.67%
ROIC Less NNEP Spread (ROIC-NNEP)		 -20.80% -24.39% -339.75% 312.21% -71.35% -202.98% -40.81% -18.87% -11.64% -14.37% -1.30%
Return on Net Nonoperating Assets (RNNOA)		 1.17% 2.01% 2.27% 12.86% 20.93% 151.93% 30.28% 11.44% 6.46% 7.98% 0.60%
Return on Equity (ROE)		 1.35% -1.59% 0.96% 0.57% 3.16% 98.90% -10.30% -8.33% -3.16% -11.94% 1.27%
Cash Return on Invested Capital (CROIC)		 11.75% -21.61% -2.19% -25.41% 85.68% -58.98% -67.98% -53.52% -0.48% -13.91% -28.90%
Operating Return on Assets (OROA)		 0.27% -2.57% -1.03% -11.02% -10.93% -14.77% -13.04% -9.33% -5.00% -10.04% 0.95%
Return on Assets (ROA)		 0.70% -0.84% 0.55% 0.34% 1.92% 76.69% -8.97% -6.97% -2.58% -9.47% 0.99%
Return on Common Equity (ROCE)		 1.35% -1.59% 0.96% 0.57% 3.16% 98.90% -10.30% -8.33% -3.16% -11.94% 1.27%
Return on Equity Simple (ROE_SIMPLE)		 1.29% -1.57% 0.96% 0.56% 3.13% 77.29% -11.45% -8.35% -3.18% -12.82% 1.25%
Net Operating Profit after Tax (NOPAT)		 1.09 -23 -9.14 -92 -93 -139 -127 -84 -46 -88 3.35
NOPAT Margin		 0.14% -2.84% -1.08% -52.64% -42.47% -48.56% -33.28% -19.05% -8.68% -14.76% 0.51%
Net Nonoperating Expense Percent (NNEP)		 20.98% 20.80% 338.43% -324.50% 53.57% 149.96% 0.24% -0.90% 2.03% -5.55% 1.96%
Cost of Revenue to Revenue		 62.79% 61.38% 57.45% 57.21% 43.80% 42.27% 40.12% 32.50% 27.89% 28.51% 27.21%
SG&A Expenses to Revenue		 14.50% 18.99% 17.35% 55.83% 39.93% 34.62% 28.62% 23.52% 19.78% 21.01% 16.70%
R&D to Revenue		 7.80% 9.22% 8.73% 28.25% 27.58% 30.00% 27.85% 30.50% 29.87% 31.71% 22.92%
Operating Expenses to Revenue		 37.02% 42.68% 44.09% 117.99% 116.87% 127.11% 107.41% 94.71% 84.51% 92.58% 71.06%
Earnings before Interest and Taxes (EBIT)		 3.37 -34 -13 -131 -134 -198 -181 -121 -66 -126 11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 60 47 73 -99 -96 -164 -150 -93 -49 -111 23
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.85 2.03 2.38 3.00 2.40 2.80 2.04 3.21 2.40 1.53 2.41
Price to Tangible Book Value (P/TBV)		 8.59 7.28 8.50 24.45 3.38 3.39 2.98 5.08 3.79 2.57 5.53
Price to Revenue (P/Rev)		 3.26 1.78 1.96 12.68 8.16 13.03 5.83 7.84 4.82 2.38 3.46
Price to Earnings (P/E)		 296.41 0.00 248.61 539.39 76.51 3.62 0.00 0.00 0.00 0.00 192.18
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.34% 0.00% 0.40% 0.19% 1.31% 27.64% 0.00% 0.00% 0.00% 0.00% 0.52%
Enterprise Value to Invested Capital (EV/IC)		 4.36 2.21 2.38 2.85 7.43 9.88 4.18 5.79 4.26 2.15 3.31
Enterprise Value to Revenue (EV/Rev)		 3.14 1.91 1.96 13.02 8.57 9.31 3.90 6.52 3.67 1.55 2.90
Enterprise Value to EBITDA (EV/EBITDA)		 41.91 32.79 22.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 83.44
Enterprise Value to EBIT (EV/EBIT)		 749.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 167.64
Enterprise Value to NOPAT (EV/NOPAT)		 2,317.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 570.85
Enterprise Value to Operating Cash Flow (EV/OCF)		 26.37 25.09 14.67 0.00 0.00 0.00 0.00 0.00 24.86 26.77 18.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 34.99 0.00 0.00 0.00 4.19 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.47 0.39 0.27 0.31 0.31 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.42 0.35 0.23 0.26 0.30 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.06 -0.08 -0.01 0.04 -0.29 -0.75 -0.74 -0.61 -0.55 -0.56 -0.46
Leverage Ratio		 1.93 1.89 1.74 1.66 1.64 1.29 1.15 1.19 1.22 1.26 1.28
Compound Leverage Factor		 -3.03 2.32 2.80 1.65 1.64 1.17 1.05 1.19 0.65 1.19 3.86
Debt to Total Capital		 31.75% 28.26% 21.39% 23.66% 23.45% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 2.86% 3.29% 3.63% 4.11% 0.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 28.89% 24.97% 17.76% 19.55% 23.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.25% 71.74% 78.61% 76.34% 76.55% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 5.27 5.92 2.61 -2.30 -2.39 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -1.68 2.24 0.01 -0.59 -0.93 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 4.80 5.23 2.17 -1.90 -2.38 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 291.41 -12.11 -20.79 -2.49 -2.45 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -92.65 -4.59 -0.06 -0.64 -0.96 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 265.20 -10.70 -17.27 -2.06 -2.44 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.09 2.84 3.81 3.29 3.07 17.95 8.38 12.26 7.94 5.71 7.29
Noncontrolling Interest Sharing Ratio		 -0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.67 1.80 1.68 1.60 2.02 12.53 5.55 5.00 4.42 4.09 2.78
Quick Ratio		 2.32 0.94 1.47 1.36 1.08 11.99 5.02 4.16 4.10 3.74 2.58
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 72 -137 -15 -190 450 -154 -212 -228 -2.28 -61 -145
Operating Cash Flow to CapEx		 164.54% 78.97% 177.97% 0.00% -163.06% -22.89% -263.66% -942.25% 1,735.43% 733.41% 2,483.10%
Free Cash Flow to Firm to Interest Expense		 8.33 -17.92 -1.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 11.05 7.97 14.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 4.33 -2.12 6.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.64 0.62 0.70 0.15 0.18 0.21 0.27 0.34 0.40 0.48 0.55
Accounts Receivable Turnover		 5.02 5.60 6.40 1.24 2.26 4.37 4.44 4.28 4.03 3.90 3.79
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 3.60 4.09 4.73 1.03 2.34 9.78 16.78 28.33 45.02 64.09 86.42
Accounts Payable Turnover		 14.05 14.91 14.40 2.57 3.27 4.83 3.46 2.72 2.23 2.00 2.14
Days Sales Outstanding (DSO)		 72.67 65.21 57.01 293.88 161.53 83.45 82.16 85.29 90.66 93.52 96.19
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 25.98 24.48 25.34 142.25 111.64 75.53 105.44 134.18 163.47 182.16 170.58
Cash Conversion Cycle (CCC)		 46.69 40.73 31.67 151.63 49.90 7.92 -23.28 -48.89 -72.80 -88.63 -74.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 579 693 699 798 254 269 355 499 455 429 578
Invested Capital Turnover		 1.31 1.27 1.22 0.23 0.42 1.09 1.22 1.04 1.11 1.35 1.31
Increase / (Decrease) in Invested Capital		 -71 115 6.10 98 -544 16 86 144 -44 -27 149
Enterprise Value (EV)		 2,526 1,534 1,667 2,275 1,886 2,660 1,485 2,890 1,941 922 1,912
Market Capitalization		 2,627 1,429 1,666 2,216 1,796 3,722 2,218 3,472 2,549 1,419 2,283
Book Value per Share		 $8.94 $9.10 $8.99 $9.49 $9.47 $19.51 $16.14 $16.15 $15.59 $14.31 $14.34
Tangible Book Value per Share		 $4.00 $2.54 $2.52 $1.16 $6.72 $16.09 $11.05 $10.21 $9.87 $8.55 $6.24
Total Capital		 1,000 980 889 968 979 1,331 1,088 1,081 1,063 926 949
Total Debt		 318 277 190 229 229 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 289 245 158 189 228 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -101 105 0.51 59 89 -1,061 -733 -582 -608 -497 -372
Capital Expenditures (CapEx)		 58 77 64 -14 8.64 8.64 11 2.18 4.50 4.70 4.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 26 88 -5.38 7.78 44 35 2.39 79 24 42 14
Debt-free Net Working Capital (DFNWC)		 445 260 184 178 184 1,097 735 660 631 540 385
Net Working Capital (NWC)		 416 228 152 138 182 1,097 735 660 631 540 385
Net Nonoperating Expense (NNE)		 -7.71 -12 -16 -96 -117 -1,167 -2.13 5.88 -12 31 -8.53
Net Nonoperating Obligations (NNO)		 -104 -9.88 0.51 59 -495 -1,061 -733 -582 -608 -497 -372
Total Depreciation and Amortization (D&A)		 57 80 85 32 38 34 31 28 16 14 12
Debt-free, Cash-free Net Working Capital to Revenue		 3.23% 10.91% -0.63% 4.45% 19.79% 12.42% 0.63% 17.78% 4.47% 7.12% 2.11%
Debt-free Net Working Capital to Revenue		 55.22% 32.28% 21.67% 101.93% 83.40% 384.06% 193.13% 149.08% 119.41% 90.47% 58.43%
Net Working Capital to Revenue		 51.67% 28.28% 17.88% 79.14% 82.68% 384.06% 193.13% 149.08% 119.41% 90.47% 58.43%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 ($0.14) $0.09 $0.05 $0.30 $13.71 ($1.84) ($1.36) ($0.50) ($1.79) $0.18
Adjusted Weighted Average Basic Shares Outstanding		 76.96M 78.17M 77.52M 78.51M 77.06M 68.97M 65.34M 68.41M 68.41M 66.40M 66.15M
Adjusted Diluted Earnings per Share		 $0.12 ($0.14) $0.09 $0.05 $0.29 $13.71 ($1.84) ($1.36) ($0.50) ($1.79) $0.17
Adjusted Weighted Average Diluted Shares Outstanding		 76.96M 78.17M 77.52M 78.51M 77.06M 68.97M 65.34M 68.41M 68.41M 66.40M 66.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 76.96M 78.17M 77.52M 78.51M 77.06M 68.97M 65.34M 68.41M 68.41M 66.40M 66.15M
Normalized Net Operating Profit after Tax (NOPAT)		 19 -23 -4.36 -92 -93 -139 -127 -84 -46 -88 7.98
Normalized NOPAT Margin		 2.30% -2.84% -0.51% -52.64% -42.47% -48.56% -33.28% -19.05% -8.68% -14.76% 1.21%
Pre Tax Income Margin		 -0.66% -5.14% -2.39% -74.82% -60.44% -62.80% -43.50% -27.27% -6.63% -19.92% 5.21%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.39 -4.39 -1.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.13 -2.98 -1.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -6.32 -14.48 -9.97 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -6.59 -13.07 -9.52 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 6.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 605.06% -89.46% 787.17% 743.48% 378.55% 7.24% -146.32% -46.87% -173.27% -126.36% 509.23%

Quarterly Metrics and Ratios for Acxiom

This table displays calculated financial ratios and metrics derived from Acxiom's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 19.49% 15.56% 12.81% 4.87% 8.31% 8.68% 9.62% 15.63% 14.21% 16.02% 12.39%
EBITDA Growth		 -33.08% -801.87% -129.49% -95.43% 133.37% 147.54% 190.25% 75.64% -67.99% 18.52% 12.31%
EBIT Growth		 -41.49% -334.71% -70.74% -68.50% 109.12% 130.54% 163.47% 69.71% -331.19% -8.78% -3.47%
NOPAT Growth		 23.77% -371.08% -73.72% -68.50% 97.18% 112.31% 155.63% 69.71% -626.41% -55.78% -19.91%
Net Income Growth		 -256.74% -373.27% -93.07% -6.71% 94.17% 115.98% 147.09% 82.87% -372.19% -64.38% -19.80%
EPS Growth		 -260.00% -400.00% -100.00% -11.63% 95.00% 115.56% 145.65% 81.25% -450.00% -57.14% -19.05%
Operating Cash Flow Growth		 -93.54% 96.08% -38.09% -47.98% 177.00% 67.32% 4.98% -9.85% -136.31% 55.45% 172.51%
Free Cash Flow Firm Growth		 109.60% 122.88% 127.47% -126.69% 433.68% 134.53% 53.95% -2,376.50% -337.52% -329.91% -387.87%
Invested Capital Growth		 -6.28% -10.25% -9.95% -5.84% -16.65% -16.17% -9.35% 34.70% 46.27% 46.06% 37.94%
Revenue Q/Q Growth		 0.37% 3.41% 7.83% -6.30% 3.66% 3.77% 8.76% -1.16% 2.39% 5.41% 5.35%
EBITDA Q/Q Growth		 12.71% -10.56% 11.17% -127.98% 114.91% 57.50% 68.62% -161.54% 119.58% 483.15% 59.78%
EBIT Q/Q Growth		 10.96% -7.91% 10.88% -96.78% 104.82% 261.59% 85.20% -193.91% 63.24% 242.66% 95.98%
NOPAT Q/Q Growth		 8.46% -13.75% 17.76% -96.78% 98.47% 596.26% 271.59% -207.15% 63.24% 130.21% 572.98%
Net Income Q/Q Growth		 7.40% -11.82% 2.47% -5.66% 94.94% 406.62% 187.42% -138.44% -39.38% 123.13% 547.23%
EPS Q/Q Growth		 6.98% -12.50% -2.22% -4.35% 95.83% 450.00% 200.00% -142.86% -22.22% 127.27% 466.67%
Operating Cash Flow Q/Q Growth		 -156.61% 164.06% -26.22% 94.45% -16.21% 39.20% -53.71% 66.97% -133.74% 696.01% -18.85%
Free Cash Flow Firm Q/Q Growth		 -35.78% 118.93% 0.28% -118.93% 1,383.99% -3.79% -34.17% -404.55% -23.15% 6.87% 17.58%
Invested Capital Q/Q Growth		 9.24% -4.63% -3.45% -6.39% -3.30% -4.07% 4.40% 39.09% 5.01% -4.21% -1.40%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 71.16% 71.24% 72.71% 70.75% 70.39% 74.22% 74.16% 72.23% 70.59% 72.38% 71.86%
EBITDA Margin		 -13.47% -14.40% -11.86% -28.87% 4.15% 6.30% 9.77% -6.08% 1.16% 6.44% 9.76%
Operating Margin		 -18.00% -19.80% -15.10% -31.71% 1.47% 5.13% 8.74% -8.31% -2.98% 4.04% 7.51%
EBIT Margin		 -17.51% -18.27% -15.10% -31.71% 1.47% 5.13% 8.74% -8.31% -2.98% 4.04% 7.51%
Profit (Net Income) Margin		 -19.13% -20.69% -18.71% -21.10% -1.03% 3.04% 8.04% -3.13% -4.26% 0.93% 5.74%
Tax Burden Percent		 109.30% 113.25% 120.25% 73.99% -22.28% 33.22% 64.09% 58.37% 931.47% 14.82% 59.93%
Interest Burden Percent		 100.00% 100.00% 103.07% 89.95% 313.61% 178.35% 143.46% 64.48% 15.32% 156.06% 127.49%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 122.28% 69.42% 38.65% 0.00% 0.00% 85.18% 49.10%
Return on Invested Capital (ROIC)		 -13.52% -15.80% -12.89% -29.95% -0.44% 2.24% 7.82% -7.62% -2.79% 0.86% 5.64%
ROIC Less NNEP Spread (ROIC-NNEP)		 -11.77% -13.84% -10.35% -30.25% -0.22% 1.77% 6.87% -8.69% -1.89% 0.72% 4.82%
Return on Net Nonoperating Assets (RNNOA)		 5.97% 7.01% 5.30% 16.80% 0.12% -0.95% -3.64% 4.02% 0.86% -0.34% -2.32%
Return on Equity (ROE)		 -7.56% -8.78% -7.59% -13.15% -0.32% 1.29% 4.17% -3.60% -1.93% 0.52% 3.32%
Cash Return on Invested Capital (CROIC)		 -3.53% -2.67% -4.97% -13.91% 3.13% 7.86% 92.07% -28.90% -37.46% -37.40% -31.95%
Operating Return on Assets (OROA)		 -7.78% -8.45% -7.10% -15.09% 0.75% 2.69% 4.65% -4.56% -1.72% 2.40% 4.42%
Return on Assets (ROA)		 -8.50% -9.57% -8.80% -10.05% -0.52% 1.60% 4.28% -1.72% -2.45% 0.56% 3.37%
Return on Common Equity (ROCE)		 -7.56% -8.78% -7.59% -13.15% -0.32% 1.29% 4.17% -3.60% -1.93% 0.52% 3.32%
Return on Equity Simple (ROE_SIMPLE)		 -7.80% -10.67% -12.80% 0.00% -10.13% -6.27% -1.49% 0.00% 0.63% 0.31% 0.01%
Net Operating Profit after Tax (NOPAT)		 -18 -20 -17 -33 -0.51 2.51 9.33 -9.99 -3.67 1.11 7.47
NOPAT Margin		 -12.60% -13.86% -10.57% -22.20% -0.33% 1.57% 5.36% -5.81% -2.09% 0.60% 3.82%
Net Nonoperating Expense Percent (NNEP)		 -1.76% -1.95% -2.55% 0.29% -0.21% 0.47% 0.94% 1.06% -0.90% 0.14% 0.82%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - 0.99% - - - 0.78%
Cost of Revenue to Revenue		 28.84% 28.76% 27.29% 29.25% 29.61% 25.78% 25.84% 27.77% 29.41% 27.62% 28.14%
SG&A Expenses to Revenue		 19.08% 19.52% 23.11% 22.09% 17.31% 16.27% 15.67% 17.60% 17.60% 16.91% 16.37%
R&D to Revenue		 33.51% 31.37% 27.22% 35.14% 22.40% 21.10% 21.73% 26.28% 25.07% 23.66% 21.87%
Operating Expenses to Revenue		 89.16% 91.04% 87.81% 102.46% 68.92% 69.09% 65.41% 80.54% 73.57% 68.34% 64.35%
Earnings before Interest and Taxes (EBIT)		 -25 -27 -24 -47 2.27 8.21 15 -14 -5.25 7.49 15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -19 -21 -19 -43 6.40 10 17 -10 2.05 12 19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.75 1.27 1.71 1.53 2.06 2.07 2.62 2.41 2.15 1.77 2.07
Price to Tangible Book Value (P/TBV)		 2.83 2.10 2.91 2.57 3.46 3.43 4.26 5.53 4.88 4.09 4.58
Price to Revenue (P/Rev)		 3.19 2.13 2.64 2.38 3.12 3.07 3.90 3.46 3.00 2.33 2.72
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 192.18 342.39 579.78 24,775.96
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.52% 0.29% 0.17% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.52 1.55 2.41 2.15 3.36 3.48 4.70 3.31 2.81 2.24 2.79
Enterprise Value to Revenue (EV/Rev)		 2.27 1.28 1.87 1.55 2.29 2.23 3.06 2.90 2.50 1.84 2.19
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 83.44 106.95 73.12 80.41
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 167.64 437.84 410.61 605.69
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 5.43 570.85 2,764.01 6,677.45 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 20.20 10.13 17.61 26.77 14.89 12.84 17.95 18.09 24.09 14.37 13.42
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 97.49 40.40 4.85 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.51 -0.51 -0.51 -0.56 -0.53 -0.54 -0.53 -0.46 -0.45 -0.47 -0.48
Leverage Ratio		 1.19 1.22 1.27 1.26 1.25 1.26 1.29 1.28 1.27 1.28 1.30
Compound Leverage Factor		 1.19 1.22 1.30 1.13 3.91 2.25 1.85 0.83 0.19 2.00 1.66
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.15 5.78 6.24 5.94 7.28 7.08 7.97 7.22 7.29 6.30 6.51
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.07 4.69 3.96 4.09 4.10 3.90 3.69 2.78 3.09 2.92 2.78
Quick Ratio		 4.63 4.28 3.57 3.74 3.93 3.74 3.50 2.58 2.90 2.71 2.57
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 15 34 34 -6.41 82 79 52 -159 -196 -182 -150
Operating Cash Flow to CapEx		 -1,916.66% 799.66% 8,810.06% 29,771.84% 48,477.36% 17,882.00% 748.80% 1,543.44% -4,127.43% 23,068.88% 15,998.94%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.44 0.46 0.47 0.48 0.51 0.52 0.53 0.55 0.58 0.60 0.59
Accounts Receivable Turnover		 4.01 3.96 3.57 3.90 3.71 3.74 3.41 3.79 3.59 3.86 3.56
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 46.64 53.58 60.81 64.09 63.71 74.77 74.83 86.42 99.13 109.23 98.07
Accounts Payable Turnover		 2.86 2.62 2.02 2.00 2.48 2.32 2.03 2.14 2.34 2.29 2.12
Days Sales Outstanding (DSO)		 90.95 92.15 102.20 93.52 98.29 97.66 106.90 96.19 101.59 94.65 102.67
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 127.61 139.47 180.56 182.16 147.19 157.34 179.89 170.58 156.18 159.33 172.23
Cash Conversion Cycle (CCC)		 -36.66 -47.32 -78.36 -88.63 -48.90 -59.67 -72.99 -74.39 -54.59 -64.68 -69.56
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 497 474 458 429 415 398 415 578 607 581 573
Invested Capital Turnover		 1.07 1.14 1.22 1.35 1.33 1.42 1.46 1.31 1.33 1.45 1.47
Increase / (Decrease) in Invested Capital		 -33 -54 -51 -27 -83 -77 -43 149 192 183 158
Enterprise Value (EV)		 1,251 734 1,105 922 1,393 1,385 1,950 1,912 1,701 1,300 1,597
Market Capitalization		 1,759 1,219 1,558 1,419 1,896 1,909 2,482 2,283 2,047 1,651 1,982
Book Value per Share		 $14.98 $14.30 $13.71 $14.31 $13.83 $13.93 $14.45 $14.34 $14.39 $13.99 $14.67
Tangible Book Value per Share		 $9.24 $8.64 $8.05 $8.55 $8.26 $8.41 $8.89 $6.24 $6.34 $6.05 $6.63
Total Capital		 1,006 960 912 926 919 922 946 949 952 932 958
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -508 -486 -454 -497 -504 -524 -531 -372 -345 -351 -385
Capital Expenditures (CapEx)		 1.74 2.67 0.18 0.10 0.05 0.20 2.21 1.79 0.23 0.24 0.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 74 69 67 42 30 17 30 14 50 32 27
Debt-free Net Working Capital (DFNWC)		 582 555 520 540 534 541 561 385 395 383 412
Net Working Capital (NWC)		 582 555 520 540 534 541 561 385 395 383 412
Net Nonoperating Expense (NNE)		 9.30 10 13 -1.62 1.08 -2.35 -4.65 -4.62 3.82 -0.62 -3.74
Net Nonoperating Obligations (NNO)		 -508 -486 -454 -497 -504 -524 -531 -372 -345 -351 -385
Total Depreciation and Amortization (D&A)		 5.74 5.69 5.13 4.23 4.13 1.86 1.78 3.82 7.30 4.45 4.40
Debt-free, Cash-free Net Working Capital to Revenue		 13.33% 12.07% 11.35% 7.12% 4.90% 2.75% 4.67% 2.11% 7.34% 4.47% 3.75%
Debt-free Net Working Capital to Revenue		 105.43% 97.01% 88.25% 90.47% 87.72% 87.12% 88.13% 58.43% 58.01% 54.11% 56.56%
Net Working Capital to Revenue		 105.43% 97.01% 88.25% 90.47% 87.72% 87.12% 88.13% 58.43% 58.01% 54.11% 56.56%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.40) ($0.45) ($0.46) ($0.48) ($0.02) $0.07 $0.21 ($0.08) ($0.11) $0.03 $0.17
Adjusted Weighted Average Basic Shares Outstanding		 67.14M 66.48M 64.71M 66.40M 66.19M 65.51M 66.18M 66.15M 66.61M 65.26M 65.76M
Adjusted Diluted Earnings per Share		 ($0.40) ($0.45) ($0.46) ($0.48) ($0.02) $0.07 $0.21 ($0.09) ($0.11) $0.03 $0.17
Adjusted Weighted Average Diluted Shares Outstanding		 67.14M 66.48M 64.71M 66.40M 66.19M 65.51M 66.18M 66.15M 66.61M 65.26M 65.76M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 67.14M 66.48M 64.71M 66.40M 66.19M 65.51M 66.18M 66.15M 66.61M 65.26M 65.76M
Normalized Net Operating Profit after Tax (NOPAT)		 -18 -20 -17 -33 1.59 5.75 9.33 -9.99 -3.67 5.24 7.47
Normalized NOPAT Margin		 -12.60% -13.86% -10.57% -22.20% 1.03% 3.59% 5.36% -5.81% -2.09% 2.83% 3.82%
Pre Tax Income Margin		 -17.51% -18.27% -15.56% -28.52% 4.62% 9.16% 12.54% -5.36% -0.46% 6.30% 9.57%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -114.26% -111.93% -136.55% -126.36% -118.35% -147.53% -321.23% 509.23% 938.17% 3,190.38% 113,660.00%

Frequently Asked Questions About Acxiom's Financials

When does Acxiom's fiscal year end?

According to the most recent income statement we have on file, Acxiom's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Acxiom's net income changed over the last 10 years?

Acxiom's net income appears to be on a downward trend, with a most recent value of $11.88 million in 2024, rising from $8.80 million in 2014. The previous period was -$118.70 million in 2023.

What is Acxiom's operating income?
Acxiom's total operating income in 2024 was $11.40 million, based on the following breakdown:
  • Total Gross Profit: $480.17 million
  • Total Operating Expenses: $468.77 million
How has Acxiom revenue changed over the last 10 years?

Over the last 10 years, Acxiom's total revenue changed from $805.15 million in 2014 to $659.66 million in 2024, a change of -18.1%.

How much debt does Acxiom have?

Acxiom's total liabilities were at $282.31 million at the end of 2024, a 14.5% increase from 2023, and a 55.9% decrease since 2014.

How much cash does Acxiom have?

In the past 10 years, Acxiom's cash and equivalents has ranged from $140.02 million in 2018 to $1.06 billion in 2019, and is currently $336.87 million as of their latest financial filing in 2024.

How has Acxiom's book value per share changed over the last 10 years?

Over the last 10 years, Acxiom's book value per share changed from 8.94 in 2014 to 14.34 in 2024, a change of 60.4%.


Related Companies

This page (NASDAQ:ACXM) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Why Elon put $51 million into this
While fear dominates the headlines, a silent breakthrough could turn panic into profit. The future of AI fa...
True Market Insiders | Sponsored
Will May start the next "Great Depression?"
You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...
Behind the Markets | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
All Signs Point To Collapse - 401(k)s/IRAs /Are Doomed
Retiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road Ahead
American Hartford Gold | Sponsored